stella
beta
Study to Evaluate the Safety, PK, PD, and Efficacy of PRX-102 in Japanese Patients With Fabry Disease — Stella
Recruiting
Back to Fabry Disease trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(10 sites)
Japan
Fukuoka University Chikushi Hospital, Chikushino-shi, Fukuoka
Tohoku University Hospital, Sendai, Miyagi
University of the Ryukyu Hospital, Nishihara, Okinawa
Osaka University Hospital, Suita, Osaka
Juntendo University Hospital, 3-1-3 Hongo, Bunkyo-ku, Tokyo, Bunkyo-ku, Tokyo
Show all 10 locations
View full record on ClinicalTrials.gov